Skip to search formSkip to main contentSkip to account menu

Botulinum Toxin Type A

Known as: Clostridium Botulinum Toxin Type A, BoNT/A, Botulinum Toxins, Type A 
An injectable formulation of a neurotoxin derived through the fermentation of the Hall strain of Clostridium botulinum type A with neuromuscular… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2008
Review
2008
Background: Facial aesthetics and rejuvenation are evolving rapidly due to changes in products, procedures, and patient… 
Highly Cited
2004
Highly Cited
2004
Objective.—To determine the effect of botulinum toxin type A on calcitonin gene‐related peptide secretion from cultured… 
Review
2004
Review
2004
The use of botulinum toxin type A for facial enhancement is the most common cosmetic procedure currently undertaken in the United… 
Review
2003
Review
2003
  • K. Aoki
  • Headache
  • 2003
  • Corpus ID: 36296594
The neurotoxin, botulinum toxin type A, has been used successfully, in some patients, as an analgesic for myofascial pain… 
Highly Cited
2000
Highly Cited
2000
Objective.—To assess the safety and efficacy of botulinum toxin type A (BOTOX; Allergan, Inc) in the prevention of migraine. 
Highly Cited
1999
Highly Cited
1999
Blockade of acetylcholine release by botulinum neurotoxin type A at the neuromuscular junction induces the formation of an… 
Highly Cited
1998
Highly Cited
1998
Botulinum neurotoxin type A (BoNT/A) is the potent disease agent in botulism, a potential biological weapon and an effective… 
Review
1994
Review
1994
Between 1984 and 1992, 559 patients with torticollis were treated with botulinum toxin type A (btx) injections. Twenty‐four of… 
Highly Cited
1993
Highly Cited
1993
NEUROTRANSMITTER release is potently blocked by a group of structurally related toxin proteins produced by Clostridium botulinum1… 
Review
1991
Review
1991
BOTULISM had been recognized by the 18th century, but the observation that a toxin produced by an anaerobic organism might be…